2014 annual financial data
Supernus Pharmaceuticals 2014 Net income growth
Direct answer
Net income growth was 121.54%.
Operating income was 24,230,000 USD and net income was 19,871,000 USD.
Operating cash flow was 7,733,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 122,045,000 USD
- Operating income
- 24,230,000 USD
- Net income
- 19,871,000 USD
- Operating cash flow
- 7,733,000 USD